Peptide vaccination can lead to enhanced tumor growth through specific T-cell tolerance induction

Proceedings of the National Academy of Sciences of the United States of America

Volumn 93, Issue 15, 1996, Pages 7855-7860

  Toes, René E M ^a   Offringa, Rienk ^a   Blom, Ria J J ^a   Melief, Cornelis J M ^a   Kast, W Martin ^a,b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOVINE SERUM ALBUMIN; EPITOPE; FREUND ADJUVANT; GAMMA INTERFERON; RECOMBINANT INTERLEUKIN 2; SYNTHETIC PEPTIDE; VACCINE; VIRUS PROTEIN;

ADENOVIRUS 5; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CANCER INHIBITION; CELL TRANSFORMATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DRUG DESIGN; IMMUNOLOGICAL TOLERANCE; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MOUSE; NONHUMAN; ONCOGENE RAS; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; TUMOR GROWTH; VACCINATION;

ADENOVIRUS E1A PROTEINS; ADENOVIRUSES, HUMAN; AMINO ACID SEQUENCE; ANIMALS; CELL DIVISION; CELL LINE; CELL TRANSFORMATION, NEOPLASTIC; EPITOPES; GENES, RAS; HUMANS; IMMUNITY, CELLULAR; MICE; MICE, INBRED C57BL; MICE, NUDE; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; NEOPLASMS, EXPERIMENTAL; PEPTIDES; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; T-LYMPHOCYTES, CYTOTOXIC; VACCINES, SYNTHETIC; VIRAL VACCINES;

ADENOVIRIDAE; ANIMALIA; BOVINAE; HUMAN ADENOVIRUS; HUMAN ADENOVIRUS TYPE 5;

EID: 0029798058     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.93.15.7855     Document Type: Article

References (36)

1. Greenberg, P. D. (1991) Adv. Immunol. 49, 281-335.
2. Melief, C. J. M. (1992) Adv. Cancer Res. 58, 143-175.
3. Townsend, A. R. M., Rothbard, J., Gotch, F. M., Bahadur, G., Wraith, D. & McMichael, A. J. (1986) Cell 44, 959-968.
4. Toes, R. E. M., Offringa, R., Feltkamp, M. C. W., Visseren, M. J. W., Schoenberger, S. P., Melief, C. J. M. & Kast, W. M. (1994) Behring Inst. Mitt. 94, 72-86.
5. Kast, W. M., Roux, L., Curren, J., Blom, H. J. J., Voordouw, A. C., Meloen, R. H., Kolakofsky, D. & Melief, C. J. M. (1991) Proc. Natl. Acad. Sci. USA 88, 2283-2287.
6. Schulz, M., Zinkernagel, R. M. & Hengartner, H. (1991) Proc. Natl. Acad. Sci. USA 88, 991-993.
7. Feltkamp, M. C. W., Smits, H. L., Vierboom, M. P. M., Minnaar, R. P., de Jongh, B. M., Drijfhout, J. W., ter Schegget, J., Melief, C. J. M. & Kast, W. M. (1993) Eur. J. Immunol. 23, 2242-2249.
8. Feltkamp, M. C. W., Vreugdenhil, G. R., Vierboom, M. P. M., Ras, E., van der Burg, S. H., ter Schegget, J., Melief, C. J. M. & Kast, W. M. (1995) Eur. J. Immunol. 25, 2638-2642.
9. Minev, B. R., McFarland, B. J., Spiess, P. J., Rosenberg, S. A. & Restifo, N. P. (1994) Cancer Res. 54, 4155-4161.
10. Ressing, M. E., Sette, A., Brandt, R. M. P., Ruppert, J., Wentworth, P. A., Hartman, M., Oseroff, C., Grey, H. M., Melief, C. J. M. & Kast, W. M. (1995) J. Immunol. 154, 5934-5943.
11. Vitiello, A., Ishioka, G., Grey, H. M., Rose, R., Farness, P., Lafond, R., Yuan, L., Chisari, F. V., Furze, J., Bartholomeuz, P., & Chesnut, R. W. (1995) J. Clin. Invest. 95, 341-349.
12. Aichele, P., Kyburz, D., Ohashi, P. S., Odermatt, B., Zinkernagel, R. M., Hengartner, H. & Pircher, H. (1994) Proc. Natl. Acad. Sci USA 91, 444-448.
13. Aichele, P., Brduscha-Riem, K., Zinkernagel, R. M., Hengartner, H. & Pircher, H. (1995) J. Exp. Med. 182, 261-266.
14. Kast, W. M., Offringa, R., Peters, P. J., Voordouw, A., Meloen, R. H., van der Eb, A. J. & Melief, C. J. M. (1989) Cell 59, 603-615.
15. Greaves, D. R., Wilson, F. D., Lang, G. & Kioussis, D. (1989) Cell 59, 979-986.
16. Jochemsen, A. G., Bos, J. L. & van der Eb, A. J. (1984) EMBO J. 5, 2923-2927.
17. Capon, D. J., Chen, E. Y., Tevinson, A. D., Seeburg, P. H. & Goeddel, D. V. (1982) Nature (London) 302, 33-37.
18. Toes, R. E. M., Offringa, R., Blom, R. J. J., Brandt, R. M. P., van der Eb, A. J., Melief, C. J. M. & Kast, W. M. (1995) J. Immunol. 154, 3396-3405.
19. Gausepohl, H., Kraft, M., Boulin, Ch. & Frank, R. W. (1990) in Proceedings of the 11th American Peptide Symposium, eds. Rivier, J. E. & Manshall, G. R. (ESCOM, Leiden, The Netherlands), p. 1003.
20. Sharrock, C. E. M., Kaminski, E. & Man, S. (1990) Immunol. Today 11, 281-286.
21. Strybosch, L. W. G., Buurman, W. A., Does, R. J. M., Zinken, P. H. & Groenewegen G. (1987) J. Immunol. Methods 97, 133-140.
22. Kast, W. M. & Melief C. J. M. (1991) Int. J. Cancer (Suppl.) 6, 90-94.
23. Yang, Y., Ertl, H. C. J. & Wilson, J. M. (1994) Immunity 1, 433-442.
24. Yang, Y., Li, Q., Ertl, H. C. J. & Wilson, J. M. (1995)J. Virol. 69, 2004-2015.
25. Dai, Y., Schwarz, E. M., Gu, D., Zhang, W.-W, Sarvetnick, N. & Verma, I. M. (1995) Proc. Natl. Acad. Sci. USA 92, 1401-1405.
26. Ensinger, M. J. & Ginsberg, H. S. (1972) J. Virol. 10, 328-339.
27. Rheinholdsson-Ljunggren, G., Ramqvist, T., Ährlund-Richter, L. & Dalianis, T. (1992) Int. J. Cancer 50, 142-146.
28. Mamalaki, C., Tanaka, Y., Corbella, P., Chandler, P., Simpson, E. & Kioussis, D. (1993) Int. Immunol. 5, 1285-1292.
29. Huang, L., Soldevilla, G., Leeker, M., Flavell, R. & Crispe, I. C. (1994) Immunity 1, 741-749.
30. Singer, G. G. & Abbas, A. K. (1994) Immunity 1, 366-371.
31. Kearney, E. R., Papa, K. A., Loh, D. Y. & Jenkins, M. K. (1994) Immunity 1, 327-339.
32. Zinkernagel, R. M., Moskophidis, D., Kündig, T., Oehen, S., Pircher, H. & Hengartner, H. (1993) Immunol. Rev. 131, 199-223.
33. Smilek, D. E., Wraith, D. C., Hodgkinson, S., Dwivedy, S., Steinman, L. & McDevitt, H. O. (1991) Proc. Natl. Acad. Sci. USA 88, 9633-9637.
34. Hoyne, G. F., O'Heir, R. E., Wraith, D. C., Thomas, W. R. & Lamb, J. R. (1993) J. Exp. Med. 178, 1783-1788.
35. Sayegh, M. H., Khoury, S. J., Hancock, W. W., Weiner, H. L. & Carpenter, C. B. (1992) Proc. Natl. Acad. Sci. USA 89, 7762-7766.
36. Nisco, S., Vriens, P., Hoyt, G., Lyu, S.-C, Farfan, F., Pouletty, P., Krensky, A. M. & Clayberger, C. (1994) J. Immunol. 152, 3786-3792.